Andrés Cervantes, MD, PhD, is Chair of the Educational Program for the 2010 Congress of the European Society of Medical Oncology (ESMO). OncologySTAT: Dr. Cervantes, what were the most important studies in ovarian cancer that were presented at this year’s ESMO Congress?Dr. Andres Cervantes: For me, the most important study was the ICON7 trial, which was presented during the presidential session of the ESMO Congress.1 It was a very important presentation because the paper is the result of a randomized...